It think the wording of the PR simply did not inspire a lot of investors once again.
No IND put in. Looks like there really has not been a lot of movement yet being done.
What it shows is a dragging of heels still. We had the GMP completed announcement, a CC in May announcement, the IND was going to be put in announcement, then silence, then this comes out with the IND still going to be put in with a partnership but waiting on the IND and the FDA still needing to approve which would still take time.
This is a problem with Generex. Dragging their feet.
Generex Biotechnology Corp. (GNBT) Stock Research Links